Robert W. Baird 2007 Growth Stock Conference to Webcast Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Presentation

CAMBRIDGE, Mass., May 1 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced that its presentation at the Robert W. Baird 2007 Growth Stock Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

The presentation will provide an overview of the Company and recent events. The presentation will be delivered at 2:30 p.m. CT on Tuesday, May 8, 2007 from the Four Seasons Hotel in Chicago, Ill. The presentation will be archived for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.

Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.

Contact:

Kyle Kuvalanka

(617) 761-4734

Photo: Newscom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comMillennium Pharmaceuticals, Inc.

CONTACT: Kyle Kuvalanka of Millennium Pharmaceuticals, Inc.,+1-617-761-4734

Back to news